Hosmer-Lemeshow test was used to demonstrate goodness-of-fit. Model discrimination was evaluated via concordance index and displayed via area under the receiver operator curve (AUC). The developed model was internally validated using the remaining 30% of the cohort to further assess predictive ability. RESULTS: Of the 1,357 women meeting study criteria, 974 (71.8%) had a vaginal delivery following induction. The final model consisted of eight variables, which were significantly associated with mode of delivery following induction, including maternal age, BMI, gestational age, intrapartum magnesium sulfate, need for cervical ripening, prior cesarean delivery, cervical dilation and effacement. Model calibration and discrimination were satisfactory with Hosmer-Lemeshow test p¼0.35 and an AUC (95% CI) of 0.76 (0.73, 0.79). Internal validation demonstrated similar discriminatory ability. CONCLUSION: Using information available prior to labor induction, our model can predict vaginal delivery success for women with hypertensive disorders of pregnancy and may aid in clinical decisionmaking.
INTRODUCTION: Parvovirus B19 has been associated with spontaneous abortion, hydrops fetalis, and stillbirth when acquired in pregnancy.[1] When fetal anemia is diagnosed prenatally, fetuses usually respond to a single transfusion. In surviving neonates, the post-natal course and timeframe for bone marrow recovery is not established. METHODS: A 27 year-old primigravida at 26 weeks gestation presented to her community hospital with decreased fetal movement. Work-up revealed nonimmune hydrops fetalis secondary to Parvovirus B19 infection with +IgM seroconversion, for which she transferred to our center for percutaneous umbilical blood sampling (PUBS) and transfusion. She underwent three PUBS procedures due to persistently elevated MCA Dopplers and Category II tracing prior to presenting in preterm labor at 29 weeks. Upon delivery, the neonate weighed 1490 g, Apgar scores were 4 and 7 at 1 and 5 minutes, and a venous umbilical cord gas pH was 7.45. The neonate was admitted to the NICU for prematurity and required transfusions on day of life (DOL) 0, 18, 32, and 46 for persistent Parvovirus-induced erythroblastopenia. A repeat Parvovirus B19 PCR was greater than 10,000,000 copies at DOL 43 prompting IVIG therapy. Blood counts stabilized thereafter. On DOL 73 the neonate was 3100 g and breathing on room air, discharged home without other complications. On DOL 154, the Parvovirus B19 PCR was 70,350 copies and the infant was doing well at home. CONCLUSION: We present a case of parvovirus infection acquired in the second trimester requiring multiple transfusions, with an unusual post-natal course that has yet to be described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.